NCT01305902

Brief Summary

The purpose of this pilot study is to estimate the effect size of a contingency management procedure that reinforces walking at rates consistent with the American College of Sports Medicine recommendations of 10,000 or more steps per day in older adults. We expect that participants randomized to the contingency management intervention will increase walking to a greater degree than those assigned to a standard care condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 1, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

April 9, 2019

Status Verified

April 1, 2019

Enrollment Period

1.2 years

First QC Date

February 25, 2011

Last Update Submit

April 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • number of days on which participants walked the recommended number of steps

    Weeks 1-12

Study Arms (2)

walking recommendations

NO INTERVENTION

Participants assigned to this condition will be instructed to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. Each week, they will be congratulated if they walked the target goal on any days, and encouraged to meet the goals for the upcoming week. However, they will not receive any tangible reinforcement for walking. The meetings will be brief (about 15 minutes) and will include discussions and handouts related to the health benefits of walking.

contingency management for walking

EXPERIMENTAL

Participants assigned to this condition will be asked to wear a pedometer daily and scheduled for weekly meetings over for the next 12 weeks. The meeting duration and structure will be similar to that in the standard treatment condition including the handouts, with one exception. Participants in this condition will earn tangible reinforcement in the form of prizes for walking the target number of steps per day.

Behavioral: contingency management

Interventions

Participants assigned to the experimental group will earn chances to win prizes if they have walked the recommended number of steps.

contingency management for walking

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 55 - 75 years
  • currently not physically active
  • willing and physically able as determined by physician approval to walk 10,000 steps per day
  • blood pressure of 120-159 mmHg systolic or 80-99 mmHg diastolic
  • willing to meet with research staff weekly for 12 weeks

You may not qualify if:

  • psychiatric or physical illness that could interfere with participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Connecticut Health Center

Farmington, Connecticut, 06030, United States

Location

MeSH Terms

Conditions

Substance-Related DisordersMotor Activity

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersBehavior

Study Officials

  • Nancy M Petry, Ph.D.

    University of Conncecticut Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2011

First Posted

March 1, 2011

Study Start

January 1, 2011

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

April 9, 2019

Record last verified: 2019-04

Locations